Internationally recognised prostate‑cancer specialist Dr. Himisha Beltran is Associate Professor of Medicine at Harvard Medical School and Director of Translational Research in Medical Oncology at Dana‑Farber Cancer Institute in Boston. Patients searching for a “Boston genitourinary oncologist for metastatic prostate cancer” will find that Dr. Beltran leads cutting‑edge programs that decode tumor evolution, lineage plasticity and resistance pathways in neuroendocrine prostate cancer (NEPC), a lethal subtype lacking standard therapies.
Beyond the lab, Dr. Beltran designs biomarker‑driven clinical trials and partners with molecular‑diagnostics teams to deliver liquid‑biopsy precision medicine to men worldwide. Her prolific scholarship (>200 peer‑reviewed papers, h‑index >70) and frequent media commentary on “next‑generation PSA testing,” “PSMA‑targeted radioligand therapy,” and “AR‑independent disease” make her a leading voice for evidence‑based, equitable prostate‑cancer care.
Locations:
Cancer Treated:
Insurance
Insurance changes all the time, so please call and confirm if your insurance is accepted.
- Aetna (HMO, PPO, POS)Blue Cross Blue Shield (Empire BCBS, other BCBS plans)Cigna (HMO, PPO, POS)UnitedHealthcare (HMO, PPO, POS)Oxford Health PlansHumanaMultiplan PHCSMultiplan PHCSMagnaCareAccess Medicare (NY)Better Health (Florida Medicaid)TricareHealthfirstFidelis Care (NY)EmblemHealth (formerly known as GHI)Comprehensive Health Insurance Plan (CHIP) of IllinoisEmblemHealth